Erik Phelps, EVP & Chief Admin & Legal Officer of Tempus AI Inc., Reports Disposal of Common Shares

Form 144 | TEMPUS AI Officer Eric P.Lefkofsky proposes to sell 500,000 shares with a total value of approximately $36 Million.

Tempus AI Inc. to Participate in TD Cowen’s 4th Annual Tools/Dx Revolution Conference

Bullish flow in tempus AI Inc Class A with shares up 1.33%

Tempus AI, Inc. Director Theodore Leonsis sold 205847 Shares.

Tempus AI Inc. Director Theodore Leonsis Reports Disposal of Common Shares

Stock Track | Tempus AI Plunges 5.10% Despite AI Collaboration News with Northwestern University for Alzheimer's Research

BRIEF-Tempus Announces Collaboration With Northwestern University's Abrams Research Center On Neurogenomics

Tempus AI Inc. and Northwestern University Launch AI-Driven Alzheimer's Research Collaboration to Accelerate Therapeutic Discoveries

Tempus Announces Collaboration With NorthWestern University’s Abrams Research Center on Neurogenomics to Leverage AI for Alzheimer’s Disease Research

Mixed options sentiment in tempus AI Inc Class A with shares up 2.05%

Moderately bullish activity in tempus AI Inc Class A with shares up 1.99%

Option traders moderately bearish in tempus AI Inc Class A with shares down 0.31%

Why Shares of Tempus AI Are Jumping Higher This Week

Tempus AI Inc. COO Ryan Fukushima Reports Disposal of Common Shares

Director Jennifer A. Doudna Reports Disposal of Common Shares in Tempus AI Inc

CAVA, TEM, or SMCI: Which Growth Stock Could Deliver the Highest Upside?

Analysts Offer Insights on NA Companies: Tempus AI, Inc. Class A (TEM) and Rapport Therapeutics, Inc. (RAPP)

Tempus AI short report addressed issues mostly known, says TD Cowen

tempus AI Inc Class A call volume above normal and directionally bullish